Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021

Christensen, Daniel; Strange, Jarl Emanuel; Phelps, Matthew; Schjerning, A M; Sehested, Thomas S G; Gerds, Thomas Alexander; Gislason, Gunnar

doi:10.1016/j.atherosclerosis.2022.03.003

Cited by 17 publications

(13 citation statements)

References 42 publications

(46 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While previous reports have suggested increasing Australian MI hospitalisation rates from 1993 to 2010,10 the present study demonstrates that these trends have reversed after 2007, secondary to declining NSTEMI hospitalisations, in line with findings from contemporary studies from North America and Europe 2–9. Recent data from New Zealand also revealed similar trends with declines observed in STEMI and NSTEMI admissions from 2006 to 2016 16…”

Section: Discussionsupporting

confidence: 88%

“…Comparatively little data exist on MI hospitalisation rates within the Australasian region. Previous Australian data from 1993 to 2010 demonstrated a 1.98% annual increase in MI hospitalisations,10 a finding of concern, given declining trends observed in other major regions 2–9 11. It is unclear whether these trends in Australia have persisted in recent years.…”

Section: Introductionmentioning

confidence: 99%

“…As such, monitoring MI hospitalisation trends is of key public health and economic interest. Studies examining trends in MI incidence have shown declines in recent decades, including reports from North America2–4 and Europe 5–9…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Trends in myocardial infarction and coronary revascularisation procedures in Australia, 1993–2017

Lin

Gallagher

et al. 2022

Heart

View full text Add to dashboard Cite

ObjectivePrior data have shown rising acute myocardial infarction (MI) trends in Australia; whether these increases have continued in recent years is not known. This study thus sought to characterise contemporary nationwide trends in MI hospitalisations and coronary procedures in Australia and their associated economic burden.MethodsThe primary outcome measure was the incidence and time trends of total MI, ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) hospitalisations from 1993 to 2017. The incidence and time trends of coronary procedures were additionally collected, alongside MI hospitalisation costs.ResultsAdjusted for population changes, annual MI incidence increased from 216.2 cases per 100 000 to a peak of 270.4 in 2007 with subsequent decline to 218.7 in 2017. Similarly, NSTEMI incidence increased from 68.0 cases per 100 000 in 1993 to a peak of 192.6 in 2007 with subsequent decline to 162.6 in 2017. STEMI incidence decreased from 148.3 cases per 100 000 in 1993 to 56.2 in 2017. Across the study period, there were annual increases in MI hospitalisations of 0.7% and NSTEMI hospitalisations of 5.6%, and an annual decrease in STEMI hospitalisations of 4.8%. Angiography and percutaneous coronary intervention increased by 3.4% and 3.3% annually, respectively, while coronary artery bypass graft surgery declined by 2.2% annually. MI hospitalisation costs increased by 100% over the study period, despite a decreased average length of stay by 45%.ConclusionsThe rising incidence of MI hospitalisations appear to have stabilised in Australia. Despite this, associated healthcare expenditure remains significant, suggesting a need for continual implementation of public health policies and preventative strategies.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Trends in myocardial infarction and coronary revascularisation procedures in Australia, 1993–2017

Lin

Gallagher

et al. 2022

Heart

View full text Add to dashboard Cite

show abstract

“…Christensen et al 2 conducted a similar study in Denmark, showing a significant decline in incidence rates of AMI from 2005 to 2021. This study showed a 52.3% reduction in males aged 70–84 years and a 58.4% reduction in females aged 70–84 years (confidence interval 95%).…”

mentioning

confidence: 92%

Thoughts about the change in incidence, treatment, and outcomes of first myocardial infarctions across the 21st century

Ahmad

Mizori

Ahmad

et al. 2022

European Heart Journal Open

View full text Add to dashboard Cite

“…The epidemiological study on myocardial infarction in Korea points out that the prevalency in adults over 30 years was estimated to range from 0.34% to 0.70% in 2020 ( Kim et al, 2022 ). The mortality was 19.3 per 100000 populations In Denmark, from 1 January 2005, through 4 August 2021, there were 116481 inch acute myocardial informations in approximately 4.5 million Danes aged ≥18 years ( Christensen et al, 2022 ). With the extensive implementation of thrombolysis, cardiac interventional surgery, and the development of drug treatment, the dying myocardium can be effectively saved, and the prognosis of patients with myocardial infarction has greatly improved in recent years.…”

Section: Introductionmentioning

confidence: 99%

Systematic review and meta-analysis of the intervention effect of curcumin on rodent models of myocardial infarction

Pang

Wang²,

Ji³

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

Objective: This study aimed to evaluate the intervention effect of curcumin in myocardial infarction rodent models.Methods: A systematic retrieval of relevant studies on curcumin intervention in rats or mice myocardial infarction models was conducted, and the data were extracted. The outcome indicators included biochemical blood indicators, such as creatine kinase (CK), creatine kinase isoenzyme (CK-MB), malondialdehyde (MDA), lactate dehydrogenase (LDH) and superoxide dismutase (SOD), as well as cardiac tissue structure indicators, such as left ventricular weight to body weight ratio (LVW/BW), apoptosis index, left ventricular end-diastolic dimension (LVEDD), left ventricular end-systolic diameter (LVESD), and myocardial infarction area, and hemodynamic indexes, such as systolic blood pressure (SBP), diastolic blood pressure (DBP), left ventricular end-diastolic pressure (LVEDP), left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), maximum rate of left ventricular pressure rise (+dp/dtmax), and maximum rate of left ventricular pressure decline (–dp/dtmax). These results were then analyzed by meta-analysis. Studies were evaluated for methodological quality using the syrcle’s bias risk tool.Results: A total of 24 studies were included in the meta-analysis. The quality assessment of included studies revealed that the evidence was low quality and none of studies was judged as having a low risk of bias across all domains. The results revealed that curcumin could reduce CK-MB, CK, LDH, and MDA levels. They also revealed that it could lower SBP, DBP, LVEDP, LVW/BW, apoptosis index, LVEDD, LVESD, and myocardial infarction area and increase LVEF, LVFS, +dp/dtmax, and–dp/dtmax. However, it had no significant impact on the heart rate and the levels of SOD in the models.Conclusion: Curcumin alleviates myocardial injury and oxidative stress in myocardial infarction rodent models in terms of blood biochemistry indicators, improves the diastolic and systolic capacity of the ventricle in terms of hemodynamic indexes, and reduces the necrosis and apoptosis of cardiomyocytes in terms of tissue structure. The methodological quality of the studies was low and additional research is warranted.

show abstract

Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021

Cited by 17 publications

References 42 publications

Trends in myocardial infarction and coronary revascularisation procedures in Australia, 1993–2017

Trends in myocardial infarction and coronary revascularisation procedures in Australia, 1993–2017

Thoughts about the change in incidence, treatment, and outcomes of first myocardial infarctions across the 21st century

Systematic review and meta-analysis of the intervention effect of curcumin on rodent models of myocardial infarction

Contact Info

Product

Resources

About